RESTYLANE® LYFT with Lidocaine [European Edition]
RESTYLANE® LYFT with Lidocaine [European Edition] – 1mL × 1 Syringe | Galderma, Sweden
RESTYLANE® LYFT with Lidocaine [European Edition] is Galderma’s robust HA filler designed for deep dermal or subcutaneous injection. Using NASHA™ technology and a higher gel hardness, it provides effective lifting and volume restoration to areas such as the cheeks, midface, jawline, and nasal bridge. Lidocaine is included to improve patient comfort during treatment.
Field Name | Example Value |
---|---|
Product Name | RESTYLANE® LYFT with Lidocaine [European Edition] – 1mL × 1 Syringe |
Product Code | RES-EU-LYF-LD-1 |
Product Type | Injectable Filler / Hyaluronic Acid |
Category | Dermal Filler / Volume Restoration / Facial Contouring |
Manufacturer | Galderma Sweden AB |
Appearance | Transparent, highly cross-linked HA gel in sterile pre-filled syringe |
Dosage / Units | 1mL per syringe |
Purity | Non-animal stabilized hyaluronic acid (NASHA™) + 0.3% lidocaine |
Quantity Options | 1 syringe per box |
Storage | Store at 2–25°C; do not freeze; protect from light |
Shelf Life | 24 months unopened |
Packaging | CE-certified European Galderma box with multilingual insert and serialization |
Manufacturer Origin | Sweden |
Use Classification | Export Only – For licensed professional use only; not for over-the-counter or cosmetic retail |
Tags | restylane lyft, deep filler, volume restoration, galderma, cheek filler, jawline, lidocaine, EU edition, BLUEBIOTECH |
⚠️This product is labeled for Research Use Only (RUO). Not for human or veterinary therapeutic use.
See RUO Declaration for more info.
RESTYLANE® LYFT with Lidocaine – Deep Volume & Structural Filler | European Edition
Product Overview
RESTYLANE® LYFT with Lidocaine is a powerful structural dermal filler designed for deep volumization and facial contouring, produced by Galderma (Q-Med AB, Sweden). It utilizes NASHA™ Technology (Non-Animal Stabilized Hyaluronic Acid) to deliver high-lift capacity and structural support — ideal for restoring age-related volume loss in the midface, cheeks, chin, and hands.
This European Edition version is CE-certified for medical use across Europe and export markets. With the addition of 0.3% lidocaine, treatment is more comfortable without compromising lifting precision or product integrity.
Key Features & Benefits
-
✅ High Lifting Capacity
Densely cross-linked HA gel designed for deep dermal or subcutaneous injection, ideal for structural augmentation. -
✅ With Lidocaine for Comfort
Integrated local anesthetic (0.3%) ensures a more tolerable injection experience. -
✅ Versatile Structural Use
Enhances cheeks, chin, jawline, and dorsum of hands — areas that require strong tissue support. -
✅ Swedish-Made, EU-Certified
Manufactured by Galderma in Sweden, CE-marked and used by aesthetic professionals globally. -
✅ Natural-Looking Results with Longevity
Results typically last up to 12 months depending on the area and patient metabolism.
Product Specifications
-
Product Name: RESTYLANE® LYFT with Lidocaine – EU Edition
-
HA Concentration: 20 mg/mL
-
Lidocaine: 0.3%
-
Form: Clear, stabilized hyaluronic acid gel
-
Volume: 1mL per syringe
-
Needles: 2 × 27G
-
Injection Depth: Deep dermis to subcutaneous tissue
-
Manufacturer: Galderma / Q-Med AB (Sweden)
-
Storage: 2°C – 25°C
-
Shelf Life: 24 months from production
Recommended Treatment Areas
-
Cheekbone projection & midface volume
-
Chin definition & profile balancing
-
Jawline contouring
-
Back of the hands (volume restoration)
How It Works
RESTYLANE® LYFT with Lidocaine integrates into the deeper dermal and subcutaneous layers, where its high-viscosity NASHA™ gel provides robust lift and contour. It stimulates dermal hydration while acting as a scaffold for long-term support. The lidocaine ensures patient comfort throughout the procedure, reducing the need for topical anesthetics.
Galderma’s clinical data shows visible improvement in facial symmetry, projection, and skin firmness after just one session. Retreatment is typically recommended every 9–12 months depending on patient needs.
Reference:
Galderma Aesthetic Science – RESTYLANE® LYFT Overview
Compliance Statement
This product is manufactured in Sweden by Galderma and complies with European CE Medical Device certification. It is intended for professional medical aesthetic use and must be administered by licensed healthcare professionals only. Not for consumer resale or home use. All importers and end users are responsible for ensuring adherence to local regulatory requirements.
Tags / Keywords
Restylane Lyft, Galderma Lyft Filler, Deep Volume Filler, Cheek Filler, Chin Augmentation Injection, Subcutaneous HA Gel, Structural Dermal Filler, European CE Filler, Hyaluronic Acid with Lidocaine, Swedish-Made Dermal Filler
Also in GLP-1 Peptides:
Similar Products
Corporate Advantages

High-Purity Standards
Tested for purity and identity. COAs available
for all RUO compounds

Buyer Protection
Protected and discrete fulfillment
available upon request

Research-Grade Support
Dedicated service for labs, clinics, and
compounders handling RUO items.

Lab-Grade Quality Assurance
All compounds are tested for-identity and purity, COAs and supporting documentation are available upon request.

Strict RUO Compliance
All products are labeled for Researd Use Only (RUO), Not intended for human or veterinary therapeutic or diagnostic purposes.
Lab-Grade Quality Assurance

Custom branding.
white-label optionons and formulation assistancee available for eligible research institutions and partners.
Custom R&D & APl Synthesis

We support original
pharmaceutica solutions.custom research projects, and NDC-grade materials-meeting speifica.tions for qualified partners.

Serving Professionals Across the U.S.& Mexico
Trusted by MedSpas, wellness clinics and licensed compounders under licensed compounding relationships.
Secure & Discreet Fulfillment
Cold-chain shipping : private, plain.wrap packaging, and tracking for sensitive RUO materials.

⚠️ All compounds are provided strictly for Research Use Only (RUO). BLUEBIOTECH does not endorse or support clinical, therapeutic, or diagnostic use of its products unless under licensed compounder supervision.